Lupin launches generic version of Brovana in US
It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD
Lupin announced the launch of the authorised generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcgꝉ/2 mL, unit-dose vials, of Sunovion Pharmaceuticals.
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is for use by nebulisation only.
- Advertisement -
Nice Post.